• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺移植受者中有无肺部感染的气道微生物组存在差异。

Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection.

机构信息

Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, BMC B14, 221 84, Lund, Sweden.

Division of Infectious Diseases, Skåne University Hospital Lund, Lund, Sweden.

出版信息

Respir Res. 2021 Apr 23;22(1):118. doi: 10.1186/s12931-021-01724-w.

DOI:10.1186/s12931-021-01724-w
PMID:33892717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8063417/
Abstract

BACKGROUND

Lung transplant (LTx) recipients are at increased risk for airway infections, but the cause of infection is often difficult to establish with traditional culture-based techniques. The objectives of the study was to compare the airway microbiome in LTx patients with and without ongoing airway infection and identify differences in their microbiome composition.

METHODS

LTx recipients were prospectively followed with bronchoalveolar lavage (BAL) during the first year after transplantation. The likelihood of airway infection at the time of sampling was graded based on clinical criteria and BAL cultures, and BAL fluid levels of the inflammatory markers heparin-binding protein (HBP), IL-1β and IL-8 were determined with ELISA. The bacterial microbiome of the samples were analysed with 16S rDNA sequencing and characterized based on richness and evenness. The distance in microbiome composition between samples were determined using Bray-Curtis and weighted and unweighted UniFrac.

RESULTS

A total of 46 samples from 22 patients were included in the study. Samples collected during infection and samples with high levels of inflammation were characterized by loss of bacterial diversity and a significantly different species composition. Burkholderia, Corynebacterium and Staphylococcus were enriched during infection and inflammation, whereas anaerobes and normal oropharyngeal flora were less abundant. The most common findings in BAL cultures, including Pseudomonas aeruginosa, were not enriched during infection.

CONCLUSION

This study gives important insights into the dynamics of the airway microbiome of LTx recipients, and suggests that lung infections are associated with a disruption in the homeostasis of the microbiome.

摘要

背景

肺移植(LTx)受者发生气道感染的风险增加,但传统的基于培养的技术往往难以确定感染的原因。本研究的目的是比较 LTx 受者中持续气道感染和无持续气道感染患者的气道微生物组,并确定其微生物组组成的差异。

方法

前瞻性地对 LTx 受者进行随访,在移植后第一年进行支气管肺泡灌洗(BAL)。根据临床标准和 BAL 培养物对采样时发生气道感染的可能性进行分级,并通过 ELISA 测定 BAL 液中肝素结合蛋白(HBP)、IL-1β和 IL-8 的炎症标志物水平。使用 16S rDNA 测序分析样本的细菌微生物组,并基于丰富度和均匀度进行特征描述。使用 Bray-Curtis 和加权和非加权 UniFrac 确定样本之间微生物组组成的距离。

结果

共纳入 22 例患者的 46 个样本。感染期间采集的样本和炎症水平较高的样本表现为细菌多样性丧失和明显不同的物种组成。感染和炎症期间 Burkholderia、Corynebacterium 和 Staphylococcus 富集,而厌氧菌和正常口咽菌群较少。BAL 培养中最常见的发现,包括铜绿假单胞菌,在感染期间并未富集。

结论

本研究深入了解了 LTx 受者气道微生物组的动态变化,并提示肺部感染与微生物组的平衡失调有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/425b5ed6320a/12931_2021_1724_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/dfb912c83089/12931_2021_1724_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/4745339e2dee/12931_2021_1724_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/d6365d5d8abf/12931_2021_1724_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/425b5ed6320a/12931_2021_1724_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/dfb912c83089/12931_2021_1724_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/4745339e2dee/12931_2021_1724_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/d6365d5d8abf/12931_2021_1724_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06d6/8063417/425b5ed6320a/12931_2021_1724_Fig4_HTML.jpg

相似文献

1
Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection.肺移植受者中有无肺部感染的气道微生物组存在差异。
Respir Res. 2021 Apr 23;22(1):118. doi: 10.1186/s12931-021-01724-w.
2
Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients.肝素结合蛋白、溶菌酶和炎症细胞因子在支气管肺泡灌洗液中作为肺移植患者肺部感染的诊断工具。
Am J Transplant. 2018 Feb;18(2):444-452. doi: 10.1111/ajt.14458. Epub 2017 Sep 15.
3
Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.肺移植后肺部富集的生物体和异常的细菌及真菌呼吸道微生物组。
Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45. doi: 10.1164/rccm.201204-0693OC. Epub 2012 Jul 12.
4
Microbiome and metabolome patterns after lung transplantation reflect underlying disease and chronic lung allograft dysfunction.肺移植后微生物组和代谢组模式反映了潜在疾病和慢性肺移植物功能障碍。
Microbiome. 2024 Oct 9;12(1):196. doi: 10.1186/s40168-024-01893-y.
5
Comparison of the upper and lower airway microbiome in early postoperative lung transplant recipients.比较早期肺移植术后患者上、下呼吸道微生物组。
Microbiol Spectr. 2024 Jun 4;12(6):e0379123. doi: 10.1128/spectrum.03791-23. Epub 2024 May 15.
6
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.肺微生物组可预测慢性排斥反应肺移植受者的死亡率和阿奇霉素反应。
Am J Respir Crit Care Med. 2024 Jun 1;209(11):1360-1375. doi: 10.1164/rccm.202308-1326OC.
7
Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.高级肺部疾病中的上呼吸道生态失调与兼性优势生态型及肺移植后的动态变化。
Ann Am Thorac Soc. 2019 Nov;16(11):1383-1391. doi: 10.1513/AnnalsATS.201904-299OC.
8
Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.囊性纤维化肺移植患者下呼吸道微生物群的再度出现
Ann Am Thorac Soc. 2016 Dec;13(12):2132-2142. doi: 10.1513/AnnalsATS.201606-431OC.
9
Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together?肺移植后的气道定植与胃内容物误吸:物以类聚?
J Heart Lung Transplant. 2008 Aug;27(8):843-9. doi: 10.1016/j.healun.2008.05.022.
10
Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.阿奇霉素和同种异体移植排斥反应对肺移植术后微生物群的影响。
J Heart Lung Transplant. 2020 Feb;39(2):176-183. doi: 10.1016/j.healun.2019.11.007. Epub 2019 Nov 21.

引用本文的文献

1
Microbiosis in lung allotransplantation and xenotransplantation: State of the art and future perspective.肺同种异体移植和异种移植中的微生物群:现状与未来展望。
Health Care Sci. 2022 Sep 13;1(2):119-128. doi: 10.1002/hcs2.15. eCollection 2022 Oct.
2
Comparison of the upper and lower airway microbiome in early postoperative lung transplant recipients.比较早期肺移植术后患者上、下呼吸道微生物组。
Microbiol Spectr. 2024 Jun 4;12(6):e0379123. doi: 10.1128/spectrum.03791-23. Epub 2024 May 15.
3
Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia.

本文引用的文献

1
Ultrafast and accurate 16S rRNA microbial community analysis using Kraken 2.使用 Kraken 2 进行快速准确的 16S rRNA 微生物群落分析。
Microbiome. 2020 Aug 28;8(1):124. doi: 10.1186/s40168-020-00900-2.
2
Lung Microbiome Participation in Local Immune Response Regulation in Respiratory Diseases.肺部微生物群在呼吸道疾病局部免疫反应调节中的作用
Microorganisms. 2020 Jul 16;8(7):1059. doi: 10.3390/microorganisms8071059.
3
Challenges in the Diagnosis and Management of Bacterial Lung Infections in Solid Organ Recipients: A Narrative Review.
肺移植受者肺囊虫肺炎的肺微生物组改变。
Respir Res. 2024 Mar 14;25(1):125. doi: 10.1186/s12931-024-02755-9.
4
Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients.肺移植患者中潜在药物相互作用的患病率及临床意义
Front Pharmacol. 2024 Feb 6;15:1308260. doi: 10.3389/fphar.2024.1308260. eCollection 2024.
5
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.肺微生物组可预测慢性排斥反应肺移植受者的死亡率和阿奇霉素反应。
Am J Respir Crit Care Med. 2024 Jun 1;209(11):1360-1375. doi: 10.1164/rccm.202308-1326OC.
6
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients.假单胞菌占优势的微生物组会引起肺移植受者肺泡巨噬细胞中持续的 IL-1β 上调。
J Heart Lung Transplant. 2023 Sep;42(9):1166-1174. doi: 10.1016/j.healun.2023.04.005. Epub 2023 Apr 21.
实体器官受者细菌性肺部感染的诊断与管理难点:叙述性综述。
Int J Mol Sci. 2020 Feb 12;21(4):1221. doi: 10.3390/ijms21041221.
4
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.使用QIIME 2进行可重复、交互式、可扩展和可延伸的微生物组数据科学研究。
Nat Biotechnol. 2019 Aug;37(8):852-857. doi: 10.1038/s41587-019-0209-9.
5
Microbiological findings in bronchoalveolar lavage fluid from lung transplant patients in Sweden.瑞典肺移植患者支气管肺泡灌洗 fluid 的微生物学研究结果 。(注:这里“fluid”结合语境推测可能是“液体”,但原英文表述不太准确完整)
Transpl Infect Dis. 2018 Dec;20(6):e12973. doi: 10.1111/tid.12973. Epub 2018 Aug 27.
6
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.AERIS 研究中的肺部微生物组纵向分析表明细菌和嗜酸性 COPD 加重具有可重复性。
Thorax. 2018 May;73(5):422-430. doi: 10.1136/thoraxjnl-2017-210408. Epub 2018 Jan 31.
7
Long-term outcomes and management of lung transplant recipients.肺移植受者的长期预后和管理。
Best Pract Res Clin Anaesthesiol. 2017 Jun;31(2):285-297. doi: 10.1016/j.bpa.2017.05.006. Epub 2017 May 30.
8
Algorithm for post-clustering curation of DNA amplicon data yields reliable biodiversity estimates.基于聚类后分析的 DNA 扩增子数据校正算法可得出可靠的生物多样性估计值。
Nat Commun. 2017 Oct 30;8(1):1188. doi: 10.1038/s41467-017-01312-x.
9
Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients.肝素结合蛋白、溶菌酶和炎症细胞因子在支气管肺泡灌洗液中作为肺移植患者肺部感染的诊断工具。
Am J Transplant. 2018 Feb;18(2):444-452. doi: 10.1111/ajt.14458. Epub 2017 Sep 15.
10
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.国际心肺移植学会登记处:2017年第34次成人肺移植和心肺联合移植报告;重点主题:移植物缺血时间。
J Heart Lung Transplant. 2017 Oct;36(10):1047-1059. doi: 10.1016/j.healun.2017.07.016. Epub 2017 Jul 19.